Wave Therapeutics

Cover Block

Attribute	Wave Therapeutics
Name	Wave Therapeutics
Tagline	Smart therapeutic cushioning to prevent pressure injuries and blood clots in high-risk patients.
Headquarters	Nashville, Indiana, United States
Founded	2017
Stage	Seed [PitchBook, retrieved 2024]
Funding Label	Seed (total disclosed ~$1,610,000) [PitchBook, retrieved 2024]
Founding Team	Jessica Bussert, RN [LinkedIn, retrieved 2024]

Links

• Website: https://wavetherapeuticsinc.com
• LinkedIn: https://www.linkedin.com/company/wavetherapeuticsinc

Executive Summary

Wave Therapeutics is developing smart therapeutic cushioning to automate pressure relief and prevent costly, life-threatening injuries in immobile patients. The company's flagship product, the Wave Therapeutic Cushion, integrates a microprocessor-controlled pump to dynamically adjust pressure and perform sequential compression therapy. Founder Jessica Bussert, a registered nurse and technologist, launched the company in 2017. Differentiation rests on combining pressure redistribution and intermittent pneumatic compression into a single, automated device paired with a remote monitoring analytics platform. The company has secured early-stage backing from a consortium of regional funds and accelerators, including mHUB Ventures and Techstars, with total disclosed capital estimated at approximately $1.6 million. Its business model targets sales to long-term care facilities and hospitals.

Data Accuracy: YELLOW -- Core product description and founder role are well-corroborated; funding totals conflict between major databases.

Taxonomy Snapshot

Axis	Value
Founding Team	Jessica Bussert, RN (Founder/CEO)
Funding	Seed (~$1.6M estimated)

How the Company Got Here

Wave Therapeutics was founded in 2017 by Jessica Bussert, a registered nurse, to develop smart cushioning technology for pressure injury prevention. The company is headquartered in Nashville, Indiana, and is a woman-owned medical device startup.

Key milestones include participation in the gBETA accelerator in 2021, followed by acceptance into the Techstars and mHUB Accelerator programs. A seed round of $1 million was closed in July 2023, contributing to a total disclosed capital raise of approximately $1.61 million. The company has also secured smaller grants, including a $20,000 business plan competition win.

Public development progress includes a collaboration with the Veterans Health Administration (VHA) Innovation Ecosystem on the design of an initial wheelchair seat cushion product. The company reports its technology is patent-pending and that it is finalizing designs for manufacture with partner factories.

Data Accuracy: YELLOW -- Core founding and location facts are confirmed, but funding totals conflict between sources. Development claims are sourced from company and partner announcements.

Product and Technology

Wave Therapeutics is developing a hardware-software system aimed at a persistent and costly clinical problem. The company's flagship product is the Wave Therapeutic Cushion, a smart cushioning device that integrates a microprocessor-controlled pump to automate two established medical therapies: pressure relief and sequential compression. The core proposition is dynamic adjustment, moving beyond static foam or gel cushions to actively redistribute pressure and enhance blood flow in immobilized patients.

The technology is patent-pending, and the company is finalizing its design for manufacture with partner factories. A key differentiator is the accompanying analytics platform, which allows for remote patient monitoring by clinical staff or family members to track compliance and pressure build-up. The company has disclosed a collaboration with the Veterans Health Administration (VHA) Innovation Ecosystem and the Louis Stokes Cleveland VA Medical Center on the design and development of its initial wheelchair seat cushion product.

Future product iterations are planned to incorporate an array of sensors capable of detecting changes in skin temperature or pressure, moving the system toward a predictive monitoring tool. Public materials frame the product as a cost-saving and liability-reducing device for institutional buyers like long-term care facilities and hospitals, while also being positioned for home health and broader mobility-impaired populations.

Data Accuracy: YELLOW -- Product claims are sourced from the company website and partner announcements; technical readiness and sensor roadmap are from single-source trade coverage. The VHA collaboration is a named, public partnership.

Where the Demand Sits

The economic and human cost of pressure injuries creates a persistent, high-stakes problem for healthcare providers. The market for solutions to prevent these complications is defined by a significant, recurring financial burden on the healthcare system, driven by demographic trends, regulatory pressures, and the high cost of treatment.

Multiple healthcare industry reports cite an annual incidence of more than 2.5 million pressure injuries in the United States. The associated cost to the U.S. healthcare system is estimated in the range of $9.1 billion to $11.9 billion per year. One academic analysis suggests total costs could exceed $26.8 billion annually. The cost per individual case is substantial, with treatment adding between $20,000 and $151,000 to a patient's care per injury.

Demand is anchored by an aging population and healthcare payment reform that penalizes hospitals for hospital-acquired conditions (HACs). The primary substitute markets are traditional, passive pressure-relief surfaces and manual patient repositioning protocols. The competitive wedge for a smart cushion is its potential to automate a labor-intensive process, provide data-driven compliance monitoring, and improve outcomes beyond static solutions.

Metric	Value
Annual U.S. Pressure Injury Incidence	2.5 million patients
Annual U.S. System Cost (Low Estimate)	9.1 $B
Annual U.S. System Cost (High Estimate)	11.9 $B
Cost Per Injury (Low Estimate)	20 $K
Cost Per Injury (High Estimate)	151 $K

Data Accuracy: YELLOW -- Market sizing figures are drawn from healthcare industry and government reports, not company claims, but specific application to the smart cushioning segment is inferred.

Competitive Landscape

Wave Therapeutics enters a market defined by established medical device incumbents, specialized niche players, and a growing field of digital health startups.

Company	Positioning	Stage / Funding	Notable Differentiator
Wave Therapeutics	Smart cushioning combining dynamic pressure relief, sequential compression, and remote analytics.	Seed (~$1.6M)	Integrates automated therapy with a patient-monitoring analytics platform.
Mölnlycke	Global medical solutions company offering advanced wound care products.	Public subsidiary	Deep clinical evidence, global commercial scale, and a broad portfolio.

Competition for pressure injury prevention splits into three layers: static support surfaces (foam, gel, air mattresses), active alternating pressure systems, and digital health/remote patient monitoring (RPM) solutions. Wave's current defensible edge is the proposed integration of automated pressure relief and sequential compression with a software analytics layer. This combination is not commonly bundled in a single, smart cushion product targeted at the wheelchair and seated patient market. This edge depends on successful productization, regulatory clearance, and the generation of clinical evidence demonstrating reduced injury rates and lower total cost of care.

Data Accuracy: YELLOW -- Competitor identification is limited; Wave's positioning is based on company descriptions, while incumbent details are generalized from the sector.

Opportunity

The headline opportunity is to become the default smart cushioning platform for pressure injury prevention in post-acute and long-term care settings. The company is automating and instrumenting two medically recognized therapies: pressure relief and sequential compression. By integrating analytics for remote monitoring, the product shifts the value proposition from a passive piece of equipment to an active care management tool.

Scenario	What happens	Catalyst
VA Standard of Care	The product is adopted across the Veterans Health Administration network.	Successful completion of the ongoing collaboration with the VHA Innovation Ecosystem.
Consumer & Occupational Health Pivot	A direct-to-consumer or employer-subsidized model emerges.	Launch of a second-generation cushion with embedded sensors.
Data Platform Monetization	The analytics backend becomes a reimbursable RPM service.	Securing a CPT code for RPM related to pressure injury prevention.

Data Accuracy: YELLOW -- Growth scenarios are extrapolated from company statements and public collaborations; market cost data is from healthcare industry sources.

Sources

1. [PitchBook, retrieved 2024] Wave Therapeutics 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/266971-24
2. [LinkedIn, retrieved 2024] Wave Therapeutics | https://www.linkedin.com/company/wavetherapeuticsinc
3. [Perplexity Sonar Pro Brief, retrieved 2024] Wave Therapeutics Brief
4. [General Assembly, retrieved 2026] Jessica Bussert - General Assembly | https://generalassemb.ly/instructors/jessica-bussert/27256
5. [CB Insights, retrieved 2024] Wave Therapeutics Company Profile | https://www.cbinsights.com/company/wave-therapeutics
6. [wavetherapeuticsinc.com, retrieved 2024] Wave Therapeutics | https://wavetherapeuticsinc.com/
7. [techpoint.org, retrieved 2026] Wave Therapeutics coverage
8. [ciconiamedical.com, retrieved 2026] Meet the 10 MedTech Startups Graduating from the 2023 mHUB Accelerator | https://www.ciconiamedical.com/news/meet-the-10-medtech-startups-graduating-from-the-2023-mhub-accelerator
9. [rehabpub.com, retrieved 2026] Wave Therapeutics collaboration with VHA
10. [nethealth.com, retrieved 2026] Pressure Injury Market Data
11. [ahrq.gov, retrieved 2026] Pressure Injury Market Data
12. [rfhealth.com, retrieved 2026] Pressure Injury Market Data
13. [pmc.ncbi.nlm.nih.gov, retrieved 2026] Pressure Injury Cost Analysis
14. [mhub.org, retrieved 2026] Meet the 10 MedTech Startups Graduating from the 2023 mHUB Accelerator | https://mhub.org/blog/meet-the-medtech-startups-graduating-from-the-2023-mhub-accelerator